Navigation Links
DiscoveRx Announces Launch of New Human Primary Cell-Based Panels for Oncology Research
Date:9/12/2013

FREMONT, Calif., Sept. 12, 2013 /PRNewswire/ -- DiscoveRx Corporation, through its BioSeek division, today announced the release of an industry-first, primary human cell-based assay platform for oncology research. Consisting of primary human cell-based tumor-host model systems, this new BioMAP panel enables researchers to easily assess the phenotypic impact of candidate compounds on tumor microenvironment biology to better predict in vivo drug activities and forecast potential clinical outcomes with respect to drug efficacy and safety.

(Logo: http://photos.prnewswire.com/prnh/20130912/SF78575LOGO)

"These oncology-focused BioMAP® systems will support predictive and physiologically relevant cancer compound development from early discovery through pre-clinical development stages," said Ellen Berg, Ph.D., Scientific Director and General Manager of BioSeek. "They capture human tumor-host activities that can be modulated by a number of clinically relevant mono-therapies as well as drug combinations involving small molecule chemotherapeutics and biologics. Such BioMAP® models recapitulate complex interactions between tumor cells, stromal and/or vascular tissue and recruited, infiltrating immune cells to the tumor."

Despite a fair number of cancer drugs gaining approval for clinical use, late-stage compound attrition still remains a major issue in anticancer drug development. A critical need remains for pre-clinical models that can serve as better predictors of success in clinical trials. Scientific evidence is mounting that combination therapies using previously approved oncology drugs can be more efficacious, safe and successful than traditional mono-therapies, making the need for predictive in-vivo models more apparent. By virtue of the fact that the two compounds selected for combination therapy would have been developed independently, determining the appropriate therapeutic dosing for such combinations also continues to be technically challenging. The ability to test drug combinations in predictive models such as BioMAP can support the testing of pre-clinical strategies involving both development compounds and approved drugs.

For pricing inquiries, request for collaboration and project proposals, please send an email to busdev@bioseekinc.com.

About BioMAP

BioMAP® Systems incorporate predictive primary human cell-based disease models that generate uniquely informative activity profiles of each potential drug, assisting in the selection and development of new drug candidates. For more information on BioMAP drug discovery services, visit http://www.biomapsystems.com.

About DiscoveRx

Founded in 2000, DiscoveRx is a privately held, venture-backed company headquartered in Fremont, California, with additional offices in San Diego, CA, San Francisco, CA and Birmingham, England. DiscoveRx is a leading provider of next generation proprietary platforms for both target-based and phenotypic based drug discovery. The company holds extensive intellectual property for its core technology platforms 1) PathHunter®, HitHunter®and  InCELL Hunter™ : β-galactosidase based enzyme fragment complementation, 2) KINOMEscan® : in vitro binding assay platform and 3) BioMAP®: A three part drug discovery solution consisting of BioMAP system, proprietary database, and predictive analytics tools. Utilizing these proprietary platforms, DiscoveRx has developed and commercialized industry leading panels of over 1000 target based and primary cell based assay solutions for Oncology, Metabolic Disease, Inflammation, CNS and Cardiovascular drug discovery research. Many of DiscoveRx's innovative solutions have been widely adopted in pharmaceutical, biotechnology and academic laboratories worldwide. For more information, visit www.discoverx.com


'/>"/>
SOURCE DiscoveRx Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Entomological Society of America announces 2013 awardees
2. Entomological Foundation announces 2013 Insect Science Award winners
3. Chair Mats of Glass Company Clearly Innovative Announces the Launch of 20 New Dealers in the Midwest
4. Diamond Vision Announces New and Generous Promotion on its iLASIK in NYC Procedure
5. Physiotherapy in Singapore Clinic Urbanrehab Pte Ltd Announces the Opening of an Additional Location
6. Elsevier announces the launch of a new open access journal: Water Resources and Industry
7. NOAA announces additions to National System of Marine Protected Areas
8. FASEB announces BioArt image and video competition winners
9. Entomological Society of America announces 2013 fellows
10. Neurotechnology Announces NCheck Bio Attendance 2.0 Biometric Time and Attendance Software
11. Bert L. & N. Kuggie Vallee Foundation announces first recipients of its Young Investigator Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2016)... it has just released a new white paper authored by Zettar that covers the ... transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can be a complicated endeavor ...
(Date:11/14/2016)... Calif. , Nov. 14, 2016 /PRNewswire/ ... biometric identification market, Frost & Sullivan recognizes ... & Sullivan Award for Visionary Innovation Leadership. ... in the biometric identification market by pioneering ... verification solution for instant, seamless, and non-invasive ...
(Date:6/21/2016)... VANCOUVER, British Columbia , June 21, 2016 ... been appointed to the new role of principal ... has been named the director of customer development. ... , NuData,s chief technical officer. The moves reflect ... development teams in response to high customer demand ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... 30, 2016  GenomOncology today announced the appointment of ... Affairs.  Dr. Coleman will oversee clinical content ... knowledge-enabled platform. The GenomOncology software suite empowers molecular pathologists with ... and clinical decision support, from quality control through reporting. ... , , ...
(Date:11/30/2016)... , Nov. 30, 2016  The Allen ... Cell Collection: the first publicly available collection of ... cells that target key cellular structures with unprecedented ... Research, these powerful tools are a crucial first ... to better understand what makes human cells healthy ...
(Date:11/30/2016)... November 2016   Merck , ein ... Unterzeichnung einer Reihe von Vereinbarungen mit Evotec ... AG Screeningleistungen für Mercks Palette genetischer Reagenzien ... auf diese Bibliotheken in Kombination mit Evotecs ... Weg zur Ermittlung und Erforschung neuer Arzneimitteltargets.    ...
(Date:11/30/2016)... ... November 30, 2016 , ... Energetiq Technology, a world leader ... generation, ultra-bright, Laser-Driven Light Source, the EQ-77, at the MRS Fall Exhibit 2016. ... offers higher radiance and irradiance from a truly broadband white light source. The ...
Breaking Biology Technology: